Compare ESPR & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESPR | SBGI |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 1.1B |
| IPO Year | 2013 | 1995 |
| Metric | ESPR | SBGI |
|---|---|---|
| Price | $3.89 | $15.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $6.67 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 5.3M | 400.8K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 6.55% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $303,802,000.00 | ★ $3,337,000,000.00 |
| Revenue This Year | $26.11 | N/A |
| Revenue Next Year | N/A | $10.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.83 | N/A |
| 52 Week Low | $0.69 | $11.89 |
| 52 Week High | $4.13 | $17.88 |
| Indicator | ESPR | SBGI |
|---|---|---|
| Relative Strength Index (RSI) | 55.97 | 46.88 |
| Support Level | $3.87 | $15.09 |
| Resistance Level | $4.05 | $15.51 |
| Average True Range (ATR) | 0.20 | 0.62 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 50.00 | 20.95 |
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.